Tenet director plans sale of 10,000 shares

A Rule 144 notice registers director Richard J. Mark’s intent to sell up to 10,000 THC common shares tied to vested equity awards.

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) has a notice of proposed sale under Rule 144 filed on behalf of director Richard J. Mark. The filing covers the potential sale of 10,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. Listed share amounts arise from multiple restricted stock vesting compensation awards scheduled between May 2024 and May 2026.

Key Figures

Shares covered by Form 144: 10,000 shares Restricted stock vesting May 7, 2024: 664 shares Restricted stock vesting May 9, 2025: 3,836 shares +3 more

6 metrics

Shares covered by Form 144 10,000 shares Proposed sale of TENET HEALTHCARE CORP common stock for account of Richard J. Mark

Restricted stock vesting May 7, 2024 664 shares Common stock classified as Compensation from Restricted Stock Vesting on May 7, 2024

Restricted stock vesting May 9, 2025 3,836 shares Common stock classified as Compensation from Restricted Stock Vesting on May 9, 2025

Restricted stock vesting May 23, 2025 978 shares Common stock classified as Compensation from Restricted Stock Vesting on May 23, 2025

Restricted stock vesting May 22, 2026 840 shares Common stock classified as Compensation from Restricted Stock Vesting on May 22, 2026

Restricted stock vesting May 26, 2026 3,682 shares Common stock classified as Compensation from Restricted Stock Vesting on May 26, 2026

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 05/07/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Richard J. Mark"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for THC disclose about planned share sales?

It discloses an intended sale under Rule 144 for up to 10,000 shares of TENET HEALTHCARE CORP common stock for the account of director Richard J. Mark, with Fidelity Brokerage Services LLC acting as the broker on the NYSE.

Who is the insider involved in the TENET HEALTHCARE CORP (THC) Form 144?

The filing concerns Richard J. Mark, identified as a director of TENET HEALTHCARE CORP, for whose account the securities may be sold, with the notice signed by a representative of Fidelity Brokerage Services LLC as attorney-in-fact.

How many THC shares are covered by this Rule 144 notice?

The notice covers a proposed sale of 10,000 shares of TENET HEALTHCARE CORP common stock, as listed in the securities information section of the Form 144.

What types of equity awards are tied to the THC Form 144 filing?

The filing lists multiple Restricted Stock Vesting entries classified as Compensation in TENET HEALTHCARE CORP common stock, with vesting events dated May 7, 2024; May 9, 2025; May 23, 2025; May 22, 2026; and May 26, 2026.

Which broker is handling the proposed THC share sale under Form 144?

The securities information section identifies Fidelity Brokerage Services LLC as the broker handling the proposed sale of TENET HEALTHCARE CORP common stock, with trading expected on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 03:59 PM Accepted by SEC EDGAR 09/10/2026 - 03:58 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190100
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	MARK RICHARD J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	2634155.13	80519000	09/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2024	Restricted Stock Vesting	Issuer			664	05/07/2024	Compensation
Common	05/09/2025	Restricted Stock Vesting	Issuer			3836	05/09/2025	Compensation
Common	05/23/2025	Restricted Stock Vesting	Issuer			978	05/23/2025	Compensation
Common	05/22/2026	Restricted Stock Vesting	Issuer			840	05/22/2026	Compensation
Common	05/26/2026	Restricted Stock Vesting	Issuer			3682	05/26/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Richard J. Mark
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)